Learn about perspectives on breakthrough medicines, drug safety and preventing medication errors during a new course in UCSF's Mini Medical School beginning May 8.

The National Institute of Allergy and Infectious Diseases (NIAID) has renewed support, with major funding, for an ambitious seven-year-old international research consortium that is pioneering novel strategies for studying and testing new drugs.

A team led by UCSF scientists has received a grant of $15 million, provided over five years, to study the complex genetic factors that underlie some of the most common forms of epilepsy.

The campus community can celebrate Cinco de Mayo at the Mission Bay and Parnassus campuses this week.

Associate Dean Emerita Marilyn Flood will sign copies of her new book about the School of Nursing's first 100 years this afternoon at the UCSF Library.

UCSF's transplant nurses recently received praise for helping patients, living-donors and their families through the transplantation process.

David Kessler, MD, vice chancellor for medical affairs and dean of the UCSF School of Medicine testified on Tuesday, May 1, before the House Oversight and Investigations Committee hearing on the future of the Food and Drug Administration. Kessler was FDA Commissioner from 1990 to 1997.

One of the first major studies of pediatric stroke has revealed that as many as one fifth of children who have had strokes are at risk of a recurrence ...

A treatment for osteoporosis delivered once a year is as effective as current monthly or weekly osteoporosis regimens at reducing the incidence of bone fractures, according to a new study led by a UCSF research team.